Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea - Quiz - MDSpire

Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea

  • By

  • Dayoung Seo

  • Manho Kim

  • Mi Ji Lee

  • Min Kyung Chu

  • Soo-Jin Cho

  • Heui-Soo Moon

  • Tae-Jin Song

  • Soohyun Cho

  • Byung-Kun Kim

  • Gabriela Kivelevitch

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea

  • by Dayoung Seo, Manho Kim, Mi Ji Lee, Min Kyung Chu, Soo-Jin Cho, Heui-Soo Moon, Tae-Jin Song, Soohyun Cho, Byung-Kun Kim, Gabriela Kivelevitch

  • July 6, 2026

Related Content

Neuropsychiatric symptom profile in neurocognitive disorders and their relationship with functional decline

Assessing the efficacy of ultrasound-guided platelet-rich plasma on nerve regeneration and functional outcomes in forearm peripheral nerve injuries: a retrospective observational study

Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms